+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Oligonucleotide Therapy Market Report 2026 - Product Thumbnail Image

Oligonucleotide Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
RNA Targeting Small Molecule Drug Discovery Market Report 2026 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Red Biotechnology Market 2025-2029 - Product Thumbnail Image

Red Biotechnology Market 2025-2029

  • Report
  • August 2025
  • 215 Pages
  • Global
From
Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming Growth Factor Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Synthetic Biology: Global Markets - Product Thumbnail Image

Synthetic Biology: Global Markets

  • Report
  • August 2024
  • 137 Pages
  • Global
From
From
From
From
Gastrointestinal Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 250 Pages
  • Global
From
Loading Indicator